Evidence map›Paper›PMID 41014461›Full record

ArticleBreast cancer (Tokyo, Japan)2025

The therapeutic potential of high-intensity interval training in a breast cancer model: focus on the Hippo signaling pathway.

Maryam Hossein Rezaei, Manzumeh Shamsi Meymandi, Amirhossein Moslemizadeh, Elham Madadizadeh, Francisco José Pinto Fraga, Susana López Ortiz, Sajad Haidari, Ladan Langroudi, Mohammad Amin Rajizadeh, Hamideh Bashiri and 1 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Breast cancer (Tokyo, Japan), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Maryam Hossein Rezaei *Department of Exercise Physiology, Faculty of Physical Education, Shahid Bahonar University, Kerman, Iran.
Manzumeh Shamsi Meymandi *Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
Amirhossein MoslemizadehDepartment of Immunology, Tehran University of Medical Sciences, Tehran, Iran.
Elham MadadizadehDepartment of Exercise Physiology, Faculty of Physical Education, Shahid Bahonar University, Kerman, Iran.
Francisco José Pinto Fragai+HeALTH Strategic Research Group, Department of Health Sciences, Miguel de Cervantes European University (UEMC), 47012, Valladolid, Spain.
Susana López Ortizi+HeALTH Strategic Research Group, Department of Health Sciences, Miguel de Cervantes European University (UEMC), 47012, Valladolid, Spain.
Sajad HaidariDepartment of Immunology, Kerman University of Medical Sciences, Kerman, Iran.
Ladan LangroudiDepartment of Immunology, Kerman University of Medical Sciences, Kerman, Iran.
Mohammad Amin RajizadehPhysiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
Hamideh BashiriPhysiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran. h.bashiri@kmu.ac.ir.
Kayvan Khoramipouri+HeALTH Strategic Research Group, Department of Health Sciences, Miguel de Cervantes European University (UEMC), 47012, Valladolid, Spain. k.khoramipour@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundContact inhibition regulates cell proliferation via E-cadherin and the Hippo pathway, the dysregulation of which contributes to breast cancer; while physical exercise correlates negatively with breast cancer risk, our study proposes high-intensity interval training (HIIT) as a potential modulator of Hippo signaling to mitigate tumorigenesis, explored through experimental models.

methodsHealthy control (CTL), breast cancer (BC), healthy exercise (Ex), and cancer with exercise (BC + Ex) were the four groups into which 48 BALB/c female mice were randomly assigned. Mouse breast cancer cells (4T1) were orthotopically injected into all other groups except the CTL and Ex groups. On a treadmill, the Ex and BC + Ex groups ran for 4-10 periods at 80-100% of their maximal velocity (Vmax). Western blot analysis was used to evaluate neurofibromatosis type II (NF2), macrophage-stimulating 1 (MST1/2), large tumor suppressor kinase 1/2(LATS1/2), transcriptional enhancer factor (TEAD), vestigial-like family member 4 (VGLL4), epidermal growth factor receptor tyrosine kinase (EGFR), E-cadherin, α-catenin, β-catenin, kidney and brain expressed protein (Kibra), yes-associated protein (YAP), and transcriptional coactivator with a PDZ-bindingdomain (TAZ), as well as their phosphorylated forms.

resultsWhen compared to the BC group, the BC + Ex group had higher levels of EGFR, E-cadherin, α-catenin, β-catenin, Kibra, NF2, MST1, MST 2, LATS1, LATS 2, P-YAP, VGLL4, and P-TAZ (P < 0.01). Conversely, Ex and BC + Ex had lower levels of YAP, TAZ, and TEAD than CTL and BC (P < 0.01). In addition, tumor volume was lower in BC + Ex compared to BC (P < 0.001).

conclusionsOur observations shed light on the potential molecular mechanisms by which exercise influences cancer development and provide insights into novel therapeutic strategies targeting these pathways.

Indexed as

Breast NeoplasmsHigh-Intensity Interval TrainingPhysical Conditioning, AnimalProtein Serine-Threonine KinasesAnimalsCell Line, TumorCell ProliferationDisease Models, AnimalFemaleHippo Signaling PathwayHumansMiceMice, Inbred BALB CSignal TransductionTranscription FactorsProtein Serine-Threonine KinasesTranscription FactorsBreast cancerHIITHippo-signalingMice

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.